BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15202928)

  • 21. Liposomal systems as drug delivery vehicles for dermal and transdermal applications.
    Pierre MB; Dos Santos Miranda Costa I
    Arch Dermatol Res; 2011 Nov; 303(9):607-21. PubMed ID: 21805180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
    Lauterbach A; Müller-Goymann CC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal lipids and topical drug delivery.
    Hadgraft J; Walters KA; Guy RH
    Semin Dermatol; 1992 Jun; 11(2):139-44. PubMed ID: 1498017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and therapeutic applications of iontophoresis.
    Sieg A; Wascotte V
    J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques.
    Lanke SS; Strom JG; Banga AK
    Crit Rev Ther Drug Carrier Syst; 2009; 26(6):581-606. PubMed ID: 20402624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations.
    Xu P; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
    Münch S; Wohlrab J; Neubert RHH
    Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of sonophoresis in the administration of drugs throughout the skin.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Rodríguez-Cruz IM; Domínguez-Delgado CL
    J Pharm Pharm Sci; 2009; 12(1):88-115. PubMed ID: 19470295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined use of nanocarriers and physical methods for percutaneous penetration enhancement.
    Dragicevic N; Maibach H
    Adv Drug Deliv Rev; 2018 Mar; 127():58-84. PubMed ID: 29425769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supersaturation as a tool for skin penetration enhancement.
    Cilurzo F; Casiraghi A; Selmin F; Minghetti P
    Curr Pharm Des; 2015; 21(20):2733-44. PubMed ID: 25925122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal drug delivery.
    Prausnitz MR; Langer R
    Nat Biotechnol; 2008 Nov; 26(11):1261-8. PubMed ID: 18997767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroporation-enhanced transdermal drug delivery: Effects of logP, pK
    Chen X; Zhu L; Li R; Pang L; Zhu S; Ma J; Du L; Jin Y
    Eur J Pharm Sci; 2020 Aug; 151():105410. PubMed ID: 32505795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.